G46S (p.Gly46Ser) variant of CMA1 (Chymase)

G46S (p.Gly46Ser) in CMA1 (Chymase) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.23 / 1. The record also includes population frequency data and structural context.

G46S (p.Gly46Ser) variant details